一项评估富血小板血浆注射治疗 Peyronie 病的安全性和疗效的 2 期随机、安慰剂对照交叉试验：临床试验更新。
A Phase 2 Randomized, Placebo-controlled Crossover Trial to Evaluate Safety and Efficacy of Platelet-rich Plasma Injections for Peyronie's Disease: Clinical Trial Update.
机构信息
Desai Sethi Urology Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
出版信息
Eur Urol Focus. 2023 Jan;9(1):11-13. doi: 10.1016/j.euf.2022.08.017. Epub 2022 Sep 10.
PMID:36100520
Abstract
Intralesional injection of platelet-rich plasma for Peyronie's disease appears to be safe according to early observations from an ongoing clinical trial. Efficacy data remain elusive until completion of the trial.
摘要
根据正在进行的临床试验的早期观察结果，富血小板血浆腔内注射治疗 Peyronie 病似乎是安全的。在试验完成之前，疗效数据仍难以捉摸。
Zotero 插件